Welcome to our dedicated page for Steris Plc SEC filings (Ticker: STE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Steris’s infection-prevention empire across hospitals, pharma plants, and contract-sterilization sites means digging through dense regulatory text. Whether you need utilisation data on an ethylene-oxide facility or want to confirm how much the Life Sciences segment contributed last quarter, Steris SEC filings can feel overwhelming.
Stock Titan’s AI solves that problem. Our platform converts every Steris quarterly earnings report 10-Q filing and Steris annual report 10-K simplified into plain language, flags segment margin shifts, and highlights risk disclosures—Steris SEC filings explained simply. Real-time alerts surface Steris Form 4 insider transactions the minute they hit EDGAR, so you can monitor Steris executive stock transactions Form 4 before the market reacts. Need context on sudden news? Our summaries of Steris 8-K material events explained link straight to affected business lines.
From Steris proxy statement executive compensation that details incentive metrics to Steris insider trading Form 4 transactions tracked against upcoming product launches, Stock Titan equips investors with:
- AI-powered bullet summaries for quick comprehension
- Form-level navigation covering 10-K, 10-Q, 8-K, S-1, 13D/G and more
- Real-time push alerts for Steris Form 4 insider transactions real-time
- Side-by-side earnings report filing analysis comparing sequential quarters
Stop combing through hundreds of pages alone—understanding Steris SEC documents with AI means you get to the numbers, risks, and material changes faster, and make informed decisions with confidence.
Form 4 overview: Director Cassandra Santos reported an insider transaction in Omnicom Group Inc. (OMC) dated 07/01/2025.
- Transaction type: Acquisition of 712.4 common shares. The shares were not bought on the open market but represent deferred compensation under the 2021 Incentive Award Plan, therefore recorded at a price of $0.
- Post-transaction holdings: Santos now directly holds 3,837.65 OMC shares, which include reinvested dividends credited on 04/09/2025.
- Ownership form: Direct.
- Signatory: The filing was executed by attorney-in-fact Eric J. Cleary on 07/03/2025.
No derivative securities were reported, and there were no dispositions. The filing does not disclose any monetary consideration, market purchase, or sale, limiting its potential market impact.
Amendment No. 5 to Schedule 13D discloses that the Silver Lake–affiliated reporting persons (Global Blue Holding L.P., SL Globetrotter L.P., SL Globetrotter GP Ltd., Silver Lake Technology Associates III Cayman L.P. and Silver Lake (Offshore) AIV GP III Ltd.) have tendered all of their equity interests in Global Blue Group Holding AG (“GB”) in connection with the cash tender offer launched by Shift4 Payments, Inc. and its Swiss merger subsidiary.
The offer, which commenced on 21 March 2025 and expired one minute after 11:59 p.m. (NYC time) on 2 July 2025, met all conditions. The Silver Lake vehicles tendered:
- 34,871,499 ordinary shares held by Cayman Holdings at $7.50 per share
- 4,939,137 Series A preferred shares (convertible into ordinary shares) at $10.00 per share
- 91,230,811 ordinary shares held by Globetrotter at $7.50 per share
- 11,970,487 Series A preferred shares held by Globetrotter at $10.00 per share
In addition, 2,701,935 Global Blue warrants (Cayman Holdings) and 6,548,415 warrants (Globetrotter) were cashed-out and are no longer exercisable. As a result of these transactions, the reporting persons now report 0 shares beneficially owned (0.0% of the class) and thereby cease to be 5% holders as of 3 July 2025.
Following completion of the offer, director Joseph Osnoss resigned from the Global Blue board. The filing attaches an amended Annex A listing directors of the Silver Lake general partners and adds Exhibit 99.1 containing that information.
This amendment is limited to updating ownership, identity disclosures and purpose-of-transaction details; all other information in prior filings remains unchanged.
FAQ
What is the current stock price of Steris Plc (STE)?
What is the market cap of Steris Plc (STE)?
What is the core business of Steris Plc?
How does Steris generate its revenue?
Which markets does Steris primarily serve?
What distinguishes Steris from its competitors?
How does Steris ensure product quality and safety?
What are the key business segments of Steris Plc?
Why is Steris considered an important player in infection prevention?
